Back to RecallTracker
Health Canada Health products

Jamp-Telmisartan tablet: Overweight & Underweight tablets

Issued September 9, 2024
Issue
Affected lots may contain overweight or underweight tablets.
Hazard description
Product quality
What to do
Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada.
Product
Product name
Jamp-Telmisartan 40 mg & 80 mg tablet
Reference
ID
RA-76020